Next earnings date: 5 Aug 2025

Nath Bio-Genes (India) Limited – NSE:NATHBIOGEN.NS

Add to watchlist

INR 267.6

+80.51

+43.03%

Market open

Closed in about 4 hours

-25.21%

month

-25.21%

quarter

-8.51%

year

Market Cap	3.58B
Enterprise value	4.80B

P/E	9.83
EV/Sales	1.37
EV/EBITDA	9.32
Price/Sales	1.01
Price/Book	0.61
PEG ratio	-0.75
EPS	21.09

Revenue	3.32B
EBITDA	521.11M
Income	407.03M
Revenue Q/Q	-4.17%
Revenue Y/Y	10.39%

Profit margin	11.39%
Oper. margin	13.56%
Gross margin	52.7%
EBIT margin	13.56%
EBITDA margin	15.67%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Profit Margin

Q Y

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN.NS): Profit margin
Jun 2023	2.35B	331.80M	14.1%
Sep 2023	225.67M	20.33M	9.01%
Dec 2023	317.37M	38.19M	12.03%
Mar 2024	430.38M	16.69M	3.88%

NATHBIOGEN.NS income statement history

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN.NS): Payout ratio
Payout ratio	0%

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN.NS): Dividend Yield
2016
2017
2019
2020
2022	0.94%

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN.NS): Debt to assets
Jun 2023	0	0
Sep 2023	8467528000	2.42B	28.67%
Dec 2023	0	0
Mar 2024	8802306000	2.70B	30.71%

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN.NS): Cash Flow
Jun 2023	15.2M	0	0
Sep 2023	15.2M	0	0
Dec 2023	15.2M	0	0
Mar 2024	0	0	0

Nath Bio-Genes (India) Limited alternative data

Nath Bio-Genes (India) Limited
Employees

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN.NS): Employee count
Aug 2023	433
Sep 2023	433
Oct 2023	433
Nov 2023	433
Dec 2023	433
Jan 2024	433
Feb 2024	433
Mar 2024	433
Apr 2024	433
May 2024	433
Jun 2024	433
Jul 2024	433

Nath Bio-Genes (India) Limited
Executives

Insider	Age	Compensation
Mr. Devinder Khurana (1961) Chief Financial Officer	64	$6,020,000
Mr. Satish Kagliwal (1957) MD & Executive Director	68	$4,800,000
Mr. Dhiraj Rajesh Rathi (1994) Company Sec. & Compliance Officer	31	$507,000
Ms. Jeevanlata Nandkishor Kagliwal (1948) Executive Director	77	$20,000

Frequently Asked Questions (FAQ)

What's the price of Nath Bio-Genes (India) Limited stock today?

One share of Nath Bio-Genes (India) Limited stock can currently be purchased for approximately $267.6.
When is Nath Bio-Genes (India) Limited's next earnings date?

Nath Bio-Genes (India) Limited is estimated to report earnings on Tuesday, 5 Aug 2025.
Does Nath Bio-Genes (India) Limited pay dividends?

Yes, Nath Bio-Genes (India) Limited pays dividends and its trailing 12-month yield is 1.07% with 0% payout ratio. The last Nath Bio-Genes (India) Limited stock dividend of $0 was paid on 5 Sep 2025.
How much money does Nath Bio-Genes (India) Limited make?

Nath Bio-Genes (India) Limited has a market capitalization of 3.58B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 11.08% to 2.48B US dollars.
What is Nath Bio-Genes (India) Limited's stock symbol?

Nath Bio-Genes (India) Limited is traded on the NSE under the ticker symbol "NATHBIOGEN.NS".
What is Nath Bio-Genes (India) Limited's primary industry?

Company operates in the Basic Materials sector and Agricultural Inputs industry.
How do i buy shares of Nath Bio-Genes (India) Limited?

Shares of Nath Bio-Genes (India) Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Nath Bio-Genes (India) Limited's key executives?
Nath Bio-Genes (India) Limited's management team includes the following people:
- Mr. Devinder Khurana Chief Financial Officer(age: 64, pay: $6,020,000)
- Mr. Satish Kagliwal MD & Executive Director(age: 68, pay: $4,800,000)
- Mr. Dhiraj Rajesh Rathi Company Sec. & Compliance Officer(age: 31, pay: $507,000)
- Ms. Jeevanlata Nandkishor Kagliwal Executive Director(age: 77, pay: $20,000)
How many employees does Nath Bio-Genes (India) Limited have?

As Jul 2024, Nath Bio-Genes (India) Limited employs 433 workers.
When Nath Bio-Genes (India) Limited went public?

Nath Bio-Genes (India) Limited is publicly traded company for more then 11 years since IPO on 28 Jan 2014.
What is Nath Bio-Genes (India) Limited's official website?

The official website for Nath Bio-Genes (India) Limited is nathbiogenes.com.
How can i contact Nath Bio-Genes (India) Limited?

Nath Bio-Genes (India) Limited can be reached via phone at +91 240 237 6314.

Nath Bio-Genes (India) Limited

nathbiogenes.com

Exchange:

NSE

Full time employees:

423

Industry:

Agricultural Inputs

Sector:

Basic Materials

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers seeds for cereals, such as maize, paddy, millet, wheat, and jowar; fruit seeds; fiber and oil seeds, including cotton and mustard; and seeds for vegetables comprising chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet peeper, green paeas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements, such as WINPro GOLii, WINall, and Win Chi Win growth enhancer; and forage supplements, including NUTRIMAX GOLD and NUTRIMAX for enhanced fodder yields. The company offers its products through a network of distributors, dealers, and processing plants. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Aurangabad, India.

+91 240 237 6314

Nath House
Aurangabad, 431 005

:
ISIN: INE448G01010
CUSIP: Y6S00H102